Morning Overview

Radon exposure is linked to about 21,000 US lung cancer deaths a year

Radon, an odorless radioactive gas that seeps from soil into homes, is responsible for an estimated 21,000 lung cancer deaths each year in the United States. That figure, drawn from federal risk assessments, places radon as the second leading cause of lung cancer behind cigarette smoking. Despite decades of warnings from public health agencies, most American households have never been tested, leaving millions of people exposed to a threat that is both invisible and preventable.

How Radon Kills 21,000 Americans a Year

The 21,000-death estimate originates from a 2003 EPA risk assessment that combined occupational data from uranium miners with residential exposure studies. The EPA’s clinician guidance traces the evidence base to miner cohort studies and animal experiments that established a clear dose-response relationship between radon inhalation and lung cancer. When radon gas enters a building and decays, it releases alpha particles that damage the DNA in lung tissue. Over years of repeated exposure, that damage can trigger malignant cell growth.

The National Cancer Institute frames the annual toll as a range of 15,000 to 22,000 deaths, reflecting uncertainty in how residential exposure translates from the miner data. Either end of that range would make radon one of the deadliest environmental hazards in the country, yet it receives a fraction of the public attention directed at outdoor air pollution or contaminated water.

Why Smokers Face a Compounded Threat

Radon does not operate in isolation. Federal research shows that radon and tobacco smoke interact to multiply lung cancer risk far beyond what either hazard produces alone. The EPA’s physician-oriented materials describe a radon and smoking interaction in which the combined effect on lung tissue is greater than the sum of the two individual risks. A smoker living in a home with elevated radon faces a dramatically higher chance of developing lung cancer than a nonsmoker in the same environment.

That interaction matters for public health strategy. Smoking rates have declined substantially over the past two decades, but smoking, radon, and secondhand smoke remain the three leading causes of lung cancer in the United States. Reducing radon exposure in homes where smokers or former smokers live could yield outsized reductions in cancer incidence, because the multiplicative risk means even modest drops in radon levels translate into significant mortality benefits for that population.

The Science Behind the Estimates

The federal death toll estimate did not emerge without scrutiny. Before the EPA finalized its risk model, the agency’s Science Advisory Board Radiation Advisory Committee reviewed the proposed methodology, which was built on the National Academy of Sciences’ BEIR VI report. That peer review examined how the agency extrapolated from high-dose miner exposures to the lower, chronic exposures experienced in homes, and how it handled uncertainties in ventilation, building design, and time spent indoors.

Epidemiological studies published in the years that followed added residential-level evidence. Pooled analyses of case-control studies in North American homes and in European housing confirmed a statistically significant link between indoor radon concentrations and lung cancer, reinforcing the miner-based projections. Earlier research had already established the biological plausibility of radon-induced lung damage through laboratory experiments that showed alpha radiation from radon progeny can cause DNA breaks and mutations in lung cells. Taken together, the evidence base spans occupational epidemiology, residential case-control research, and cellular studies, giving the 21,000-death estimate a foundation that few environmental health claims can match in breadth.

A Gap Between Known Risk and Household Action

Radon can accumulate in the air of any building, regardless of age, construction type, or geographic region. The gas enters through cracks in foundations, gaps around pipes, sump pits, and other openings where a structure contacts the ground. Once inside, it can reach concentrations many times higher than outdoor levels, especially during winter months when windows stay closed and pressure differentials draw more soil gas indoors. The CDC explains that this build-up allows radioactive decay products to be inhaled deeply into the lungs, where they can damage tissue.

Testing is straightforward and inexpensive. Short-term kits cost relatively little and can be placed in a basement or ground-floor room for a few days before being mailed to a lab. Long-term detectors, which remain in place for several months, provide a more accurate annual average. If results exceed the EPA’s action level, mitigation systems that vent sub-slab air to the outdoors can typically cut indoor radon by half or more. The technology is well established and usually costs on the order of other common home repairs, such as replacing a furnace or installing new windows.

Yet testing rates remain low. No federal law requires radon disclosure in all real estate transactions, and state requirements vary widely. Some states mandate testing in schools or daycare centers but leave residential properties to the discretion of buyers and sellers. That patchwork leaves a significant portion of the housing stock untested. If mandatory disclosure were paired with subsidized testing kits in high-risk zones, the gap between known science and household behavior could narrow considerably, potentially preventing thousands of deaths each year.

Federal Efforts to Close the Prevention Gap

The EPA and partner agencies have outlined a national strategy to address this disconnect between risk and action. In a recent initiative, the agency announced a coordinated plan with partner organizations aimed at eliminating preventable lung cancer deaths from radon. The effort emphasizes expanding testing in homes, schools, and workplaces; promoting mitigation in buildings that exceed the action level; and integrating radon risk communication into broader cancer prevention campaigns.

Central to this strategy is the recognition that radon control is a mature technology problem, not a scientific mystery. The EPA’s main public radon portal already provides detailed guidance on how to test, how to interpret results, and how to find certified mitigation professionals. Federal agencies encourage builders to incorporate radon-resistant construction techniques in new homes, which can prevent problems before they start and are cheaper than retrofitting older structures. Some mortgage programs and housing grants now allow or encourage radon testing and mitigation as eligible expenses, embedding prevention into housing finance.

Public health messaging is another focus. January has been designated National Radon Action Month, during which agencies and advocacy groups promote testing campaigns, distribute low-cost kits, and train health-care providers to discuss radon with patients. The EPA’s clinician resources urge doctors to ask about home testing, particularly for patients who smoke or who live in areas known to have elevated radon potential. By framing radon control as a routine part of preventive care (akin to blood pressure checks or smoking cessation counseling), officials hope to normalize testing and mitigation.

Still, significant barriers remain. Many homeowners are unaware that radon is a problem in their region, or they mistakenly believe newer homes are immune. Renters often lack authority to order tests or install mitigation systems, especially in tight housing markets. Low-income households may be reluctant to pursue testing out of concern that any identified problem would be unaffordable to fix. Federal and state programs that provide free or subsidized testing, along with financial assistance for mitigation, aim to ensure that protection from radon is not limited to those who can easily pay.

Experts stress that, unlike many environmental hazards, radon risk is highly individualized and controllable. Two neighboring houses can have very different radon levels, and only a test can reveal which one is unsafe. At the same time, the tools to reduce exposure are well understood and widely available. With clearer communication, stronger policy support, and sustained investment in outreach, the United States could sharply reduce the thousands of lung cancer deaths each year that stem from a gas no one can see or smell, and that no household needs to ignore.

More from Morning Overview

*This article was researched with the help of AI, with human editors creating the final content.